Pediatric interventional cardiology: 2009

Current Opinion in Pediatrics

Volumn 22, Issue 5, 2010, Pages 567-572

  Crystal, Matthew A ^a   Ing, Frank F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cardiac catheterization; congenital heart disease; device occluder; fetus; intervention; stent; ybrid procedure

Indexed keywords

AORTA COARCTATION; BALLOON DILATATION; DEVICE; FETAL INTERVENTION; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYBRID INTERVENTION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL LITERATURE; OCCLUDER DEVICE; PATENT FORAMEN OVALE; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; REVIEW; STENT; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CARDIOLOGY; CHILD; HEART DEFECTS, CONGENITAL; HUMANS; UNITED STATES;

EID: 77957584766     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32833e1328     Document Type: Review

References (42)

1. Law MA, Josey J, Justino J, et al. Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect. Catheter Cardiovasc Interv 2009;73:190-195.
2. Fagan T, Dreher D, Cutright W, et al. Fracture of the Gore Helex septal occluder: associated factors and clinical outcomes. Catheter Cardiovasc Interv 2009;73:941-948.
3. Rastogi N, Smeeton NC, Qureshi S. Factors related to successful transcatheter closure of atrial septal defects using the Amplatzer septal occluder. Pediatr Cardiol 2009;30:888-892.
4. Pac A, Polat TB, Cetin I, et al. Figulla ASD occluder versus Amplatzer septal occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects. J Interv Cardiol 2009;22:489-495.
5. Van den Branden BJL, Post MC, Jaarsma W, et al. New bioabsorbable septal repair implant for percutaneous closure of a patent foramen ovale: short-term results of a single-centre experience. Catheter Cardiovasc Interv 2009;74:286-290. This paper reviews short-term results of the first bioabsorbable septal occluder. This is an excellent example of technological advances in the field that promotes minimal hardware implantation.
6. Gruenstein DH, Bass JL. Experimental evaluation of a new articulated Amplatzer ductal occluder device without fabric. Catheter Cardiovasc Interv 2009;74:482-487.
7. Morgan G, Tometzki AJ, Martin RB. Transcatheter closure of long tubular patent arterial ducts: the Amplatzer duct occluder II - a new and valuable tool. Catheter Cardiovasc Interv 2009;73:576-580.
8. Saliba Z, El-Rassi I, Abi-Warde M-T, et al. The Amplatzer duct occluder II: a new device for percutaneous ductus arteriosus closure. J Interv Cardiol 2009;22:496-502.
9. Chen Z, Chen L, Wu L. Transcatheter Amplatzer occlusion and surgical closure of patent ductus arteriosus: comparison of effectiveness and costs in a low-income country. Pediatr Cardiol 2009;30:781-785.
10. Zaquot M, Suys B, de Wilde H, de Wolf D. Transthoracic echocardiography guidance of transcatheter atrial septal defect closure in children. Pediatr Cardiol 2009;30:992-994.
11. Sivakumar K, Bhagyavathy A, Gnanapragasam F. Closure of large patent ductus arteriosus in renal failure under echocardiographic guidance without use of radiographic contrast media. Congenit Heart Dis 2009;4:59-62.
12. Kenny D, Morgan G, Bajwa A, et al. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Catheter Cardiovasc Interv 2009;73:568-575.
13. Ratnayaka K, Raman VK, Faranesh AZ, et al. Antegrade percutaneous closure of membranous ventricular septal defect using X-ray fused with magnetic resonance imaging. JACC Cardiovasc Interv 2009;2:224-230. Technical feasibility and animal research are highlighted in this paper that outlines a novel approach to decrease procedure complications and radiation exposure.
14. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the Melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit: early results from the US clinical trial. JACC 2009;54:1722-1729. This is a landmark multiinstitutional US phase I trial discussing the early results of the Melody transcatheter pulmonary valve that resulted in FDA approval under a Human Device Exemption protocol.
15. Dohlen G, Chaturvedi RR, Benson LN, et al. Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot. Heart 2009;95:142-147.
16. Desai T, Stumper O, Miller P, et al. Acute interventions for stenosed right ventricle-pulmonary artery conduit following the right-sided modification of Norwood-Sano procedure. Congenit Heart Dis 2009;4:433-439.
17. Frazer JR, Ing FF. Stenting of stenotic or occluded iliofemoral veins, superior and inferior vena cavae in children with congenital heart disease: acute results and intermediate follow-up. Catheter Cardiovasc Interv 2009;73:181-188.
18. Stapleton GE, Hamzeh R, Mullins CE, et al. Simultaneous stent implantation to treat bifurcation stenoses in the pulmonary arteries: initial results and longterm follow up. Catheter Cardiovasc Interv 2009;73:557-563. This is a large series highlighting a novel stent implantation technique to treat the difficult but not uncommon problem of bifurcation stenoses in the pulmonary arteries with a thorough evaluation of early to long-term results.
19. Kretschmar O, Sglimbea A, Pretre R, Knirsch W. Pulmonary artery stent implantation in children with single ventricle malformation before and after completion of partial and total cavopulmonary connections. J Interv Cardiol 2009;22:285-290.
20. Maglione J, Bergersen L, Lock JE, McElhinney DB. Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ Cardiovasc Interv 2009;2:52-58.
21. Mohan UR, Danon S, Levi D, et al. Stent implantation for coarctation of the aorta in children <30kg. JACC Cardiovasc Interv 2009;2:877-883. This paper highlights the safety and efficacy of stenting COA in smaller children, thus extending the lower size limits of this particular intervention.
22. Tang L, Forbes TJ, Du W, Zilberman MV. Echocardiographic evaluation of pressure gradient across the stent in patients treated for coarctation of the aorta. Congenit Heart Dis 2009;4:269-272.
23. Santoro G, Capozzi G, Caianiello G, et al. Pulmonary artery growth after palliation of congenital heart disease with duct-dependent pulmonary circulation. J Am Coll Cardiol 2009;54:2180-2186.
24. Lee K-J, Hinek A, Chaturvedi RR, et al. Rapamycin-eluting stents in the arterial duct: experimental observations in the pig model. Circulation 2009;119:2078-2085.
25. Miyamoto SD, Pietra BA, Chan K-C, et al. Long-term outcome of palliation with internal pulmonary artery bands after primary heart transplantation for hypoplastic left heart syndrome. Pediatr Cardiol 2009;30:419-425.
26. Phillips ABM, Green J, Bergdall V, et al. Teaching the 'hybrid approach': a novel swine model of muscular ventricular septal defect. Pediatr Cardiol 2009;30:114-118.
27. Gardiner HM. The case for fetal cardiac intervention. Heart 2009;95:1648-1652.
28. McElhinney DB, Marshall AC, Wilkins-Haug LE, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation 2009;120:1482-1490. Thorough reviews of the innovations in our field are critical to optimizing safety and outcomes, and this manuscript highlights these concepts in a field very early in its blossoming infancy.
29. Crespo D, Miro J, Vobecky SJ, et al. Experience in a single centre with percutaneous aortic valvuloplasty in children, including those with associated cardiovascular lesions. Cardiol Young 2009;19:372-382. This publication offers a lengthy follow-up period and found no correlation between aortic valve regurgitation and the balloon-to-aortic annulus ratio. This is different from many other published findings.
30. Bouzguenda I, Marini D, Ou P, et al. Percutaneous treatment of neonatal aortic coarctation presenting with severe left ventricular dysfunction as a bridge to surgery. Cardiol Young 2009;19:244-251.
31. Morgan GJ, Chen Q, Parry A, Martin R. Balloon debanding the pulmonary artery: in vitro studies and early clinical experience. Congenit Heart Dis 2009;4:273-277.
32. McQuillen PS, Hamrick SEG, Perez MJ, et al. Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries. Circulation 2006;113:280-285.
33. Beca J, Gunn J, Coleman L, et al. Preoperative brain injury in newborn infants with transposition of the great arteries occurs at rates similar to other complex congenital heart disease and is not related to balloon atrial septostomy. J Am Coll Cardiol 2009;53:1807-1811. Previous publications highlighted the significant concern that septostomy caused increased rates of stroke. This paper is important in bringing more data to this debate.
34. Petit CJ, Rome JJ, Wernovsky G, et al. Preoperative brain injury in transposition of the great arteries is associated with oxygenation and time to surgery, not balloon atrial septostomy. Circulation 2009;119:709-716. As listed above, previous publications highlighted the significant concern that septostomy caused increased rates of stroke. This paper is important in bringing more data to this debate.
35. Asoh K, Hickey E, Dorostkar PC, et al. Outcomes of emergent cardiac catheterization following pediatric cardiac surgery. Catheter Cardiovasc Interv 2009;73:933-940. Procedures were feasible, effective and associated with a low incidence of complications. This paper highlights the need for improved exit strategies from the operating room that will allow earlier identification of residual hemodynamic lesions.
36. Marasini M, Gorrieri PF, Tuo G, et al. Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum. Heart 2009;95:1520-1524.
37. Gowda ST, Kutty S, Ebeid M, et al. Preclosure pressure gradients predict patent ductus arteriosus patients at riskfor later left pulmonary artery stenosis. Pediatr Cardiol 2009;30:883-887.
38. Roclawski M, Sabiniewicz R, Potaz P, et al. Scoliosis in patients with aortic coarctation and patent ductus arteriosus: does standard posterolateral thoracotomy play a role in the development of the lateral curve of the spine? Pediatr Cardiol 2009;30:941-945.
39. Seale AN, Webber SA, Uemura H, et al. Pulmonary vein stenosis: the UK, Ireland and Sweden collaborative study. Heart 2009;95:1944-1949.
40. Beitzke A, Gamillscheg A, Nagel B, Koestenberger M. Femoral vein access by contrast-guided puncture in cardiac catheterization in patients under one year of age. Pediatr Cardiol 2009;30:768-770.
41. Brown SC, Boshoff DE, Eyskens B, et al. Use of a microcatheter in a telescopic system to reach difficult targets in complex congenital heart disease. Catheter Cardiovasc Interv 2009;73:676-681.
42. Moszura T, Mazurek-Kula A, Dryzek P, et al. Interventions complementing surgery as part of multistage treatment for hypoplastic left heart syndrome: one center's experience. Pediatr Cardiol 2009;30:106-113.